SCHEMBL9950035

SCHEMBL9950035

O=CNC1NCc2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.35
CYP3A4 P08684 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
DRD1 P21728 4/20 0.34
MAPK1 P28482 3/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPT P10636 3/20 0.34
DRD2 P14416 3/20 0.34
DRD4 P21917 3/20 0.34
TP53 P04637 2/20 0.34
CYP1A2 P05177 2/20 0.34
HSD17B10 Q99714 2/20 0.34
KDM4E B2RXH2 2/20 0.34
HPGD P15428 2/20 0.34
CYP2C19 P33261 1/20 0.34
ADRB2 P07550 1/20 0.34
ADRB1 P08588 1/20 0.34
CYP2C9 P11712 1/20 0.34
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28139312 0.83 PRCP (0.49) ALDH1A1MAPTKDM4ETSHR
SCHEMBL10923547 0.76 CYP2D6 (0.38) CYP2D6CYP3A4KMT2AMEN1DRD1
SCHEMBL28381732 0.76 PDPK1 (0.44) CYP2D6CYP3A4KMT2AMEN1DRD1
SCHEMBL5038527 0.75 CHRNB2 (0.37) CYP2D6CYP3A4KMT2AMEN1DRD1
Hydrochloric Acid SCHEMBL11256988 0.74 PDPK1 (0.43) CYP2D6CYP3A4KMT2AMEN1MAPK1
SCHEMBL27971221 0.72 KMT2A (0.47) CYP2D6CYP3A4KMT2AMEN1MAPK1
SCHEMBL28148420 0.72 MTNR1A (0.44) CYP2D6CYP3A4DRD1MAPK1ALDH1A1
SCHEMBL30435099 0.72 CYP2D6 (0.38) CYP2D6CYP3A4KMT2AMEN1DRD1
SCHEMBL3087062 0.72 CYP2D6 (0.38) CYP2D6CYP3A4KMT2AMEN1DRD1
SCHEMBL28143456 0.71 PRCP (0.44) KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120165356-A1 SPIROCYCLIC HETEROCYCLIC DERIVATIVES AND METHODS OF THEIR USE ADOLOR CORPORATION (US) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165356-A1 SPIROCYCLIC HETEROCYCLIC DERIVATIVES AND METHODS OF THEIR USE OPRK1, OPRD1, OPRL1 CYP2D6 138/4885CYP3A4 362/4885KMT2A 2918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.